Search

everythinglearnresearchcommunity

for

Search:↓

Licorice extract helps hair growth and may treat hair loss.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.